Exchange Announcement • 13 Oct 2026 08:00
Announcement on Receipt of the Clinical Trial Approval Notice for the Company's Lyophilized Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
Exchange Announcement • 10 Oct 2026 08:00
Announcement on Wholly-owned Subsidiary Passing Turkish GMP Compliance Inspection
Exchange Announcement • 24 Sep 2026 08:00
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Exchange Announcement • 08 Sep 2026 08:00
Notice on Convening the 1st Extraordinary General Meeting in 2026
Exchange Announcement • 08 Sep 2026 08:00